Abstract-Internalization of a G-protein-coupled receptor (GPCR) is essential to the desensitization, endocytosis, and signal transduction of the receptor. It has been the general view that conventional homologous internalization of a GPCR requires activation of the G-protein(s) coupled to the receptor. However, whether and how GPCR-mediated G-protein-independent signals trigger receptor internalization remains unknown, although G-protein-independent internalization has been reported. Here we show that an angiotensin II (Ang II) type-1 (AT 1 ) receptor mutant incapable of activating any G-protein still undergoes normal internalization. Substitution of Asp 125 with Ala and Arg 126 with Leu at the highly conserved DRY motif of the AT 1 receptor disabled the ability of the receptor to activate G-proteins, as shown by various Ang II binding studies, GDP-GTP exchange, and inositol phosphate production assays. Surprisingly, the mutant internalized normally in the presence of Ang II and transactivated the epidermal growth factor receptor (EGFR). Similar to the wild-type receptor, overexpression of a dominant-negative K220R mutant GRK2 diminished the internalization of D125A-R126L but not the transactivation of EGFR. These data indicate that G-protein-independent specific signals may also trigger homologous internalizations of the AT 1 receptor through ␤-arrestin-dependent and -independent pathways, suggesting a possible mechanism for G-protein-independent activation of G-protein-coupled receptor kinases (GRKs). This may represent a general mechanism for triggering GPCR internalization. 
A gonist binding to a G-protein-coupled receptor (GPCR) induces conformational changes in the receptor, leading to activation of G␣␤␥ heterotrimers. One function of the activated G-proteins is to activate G-protein-coupled receptor kinases (GRKs) that in turn phosphorylate the specific receptor for desensitization. Subsequently, ␤-arrestins bind to the GRK-phosphorylated motifs of the receptor and induce the receptor internalization. This homologous GPCR desensitization/internalization is agonist specific and GRK dependent. This type of feedback regulation is conventional because it requires activation of classic G-proteins. [1] [2] [3] Homologous internalization of GPCRs can also take place through ␤-arrestin-independent pathway. However, the underlying mechanism and especially the role of G-protein activation in this mode of internalization remain poorly understood. 4 -6 The second messenger-stimulated kinases protein kinase A (PKA) and protein kinase C (PKC) also phosphorylate the receptor and induce heterologous desensitization/internalization that is not agonist specific. [1] [2] [3] It is known that a GPCR activates not only multiple G-protein pathways but also non-G-protein pathways. However, it remains unknown whether activation of non-G-protein signal pathways also exert homologous feedback regulations that are agonist specific.
GPCRs share common structural features, such as 7 transmembrane spanning regions (TMs), and preserve highly conserved consensus motifs, such as DRY motif at the boundary of TM3 and the second cytoplasmic loop. As a result, the GPCRs are thought to use similar mechanisms for G-protein coupling and activation. 7, 8 For example, the DRY motif is thought to play pivotal roles in all G-protein coupling and activation. A salt bridge formed between the Asp and Arg of the motif may serve as a switch for GDP-GTP exchange, an essential process required for any G-protein activation. Mutation of this motif in rhodopsin, especially the conserved Arg residue, has been shown to totally inhibit the receptor from G-protein coupling and activation. 9 Angiotensin II (Ang II) type-1 (AT 1 ) receptors exert complex and diverse physiological actions associated with many diseases or disorders such as hypertension, hypertrophy, fibrosis, thrombosis, and atherosclerosis. In addition to activation of multiple G-proteins including G q/11 , G i , and G 13 , 10 -15 AT 1 receptors activate the Jak2/STAT pathway and transactivate epidermal growth factor (EGF) and plateletderived growth factor (PDGF) receptors. 14 -18 The AT 1 receptors even activate signal pathways in a more complex fashion by forming homodimerization or heterodimerization with the AT 1 , 19 -22 AT 2 , 19 bradykinin B 2 , 23 ␤ 2 -adrenergic, 24 and dopamine D 1 25,26 receptors. In the case of these complex activations, whether and how the AT 1 -initiated discrete signals regulate the homologous internalization of the receptor, what signals trigger the homologous internalization and whether G-protein-independent signals are also capable of initiating homologous internalization remain to be addressed. It has been reported that mutations of a highly conserved Asp 74 residue in TM2 of the AT 1 receptor impaired inositol phosphate-3 (IP3) production but not agonist-induced internalization. However, the Asp 74 mutants still produced a minimal amount of IP3 27, 28 and remained sensitive to GTP␥S. 29 In this report, we show that double mutations of Asp 125 to Ala and Arg 126 to Leu (D125A-R126L) at the highly conserved DRY motif of the AT 1 receptor induced uncoupling of the receptor from all G-proteins but had little effect on the receptor internalization and the EGF receptor (EGFR) transactivation. The supernatant (100 L) was removed and added to a mixture of anti-G ␣q/11 , anti-G ␣i , and anti-G ␣s antibodies (Santa Cruz Biotechnology). Samples were incubated at 4°C overnight before addition of 50 L of protein A Sepharose. After a further incubation at 4°C for 2 hours, the Sepharose beads were washed 3ϫ with 0.5 mL of solubilization buffer minus SDS. Finally, the solubilization buffer was removed and scintillation fluid added before quantification by liquid scintillation counting.
Materials and Methods

Materials
GTP␥S and GDP Exchange Assay
Production of Total IPs
The COS-1 cells, cultured in 60-mm Petri dishes, were labeled for 24 hours with [ 3 H]myo-inositol (1 Ci/mL) at 37°C in inositol-free DMEM containing 10% bovine calf serum 24 hours after transfection. For the IP assay (ie, 48 hours after transfection), labeled cells were washed 3ϫ with serum-free medium and incubated with DMEM containing 10 mmol/L LiCl for 20 minutes. Then medium alone or ligands were added to the cells. After incubation for 45 minutes at 37°C, the medium was removed, and total soluble IP was extracted from the cells by a perchloric acid extraction method as described previously. 30 The amount of [ 3 H]-IP eluted from the column was counted and a concentration-response curve generated using iterative nonlinear regression analysis. 30 
Measurement of AT 1 Receptor Internalization
Internalization of the AT 1 receptors was measured by a method described previously. 33 Briefly, COS-1 cells, transiently transfected with AT 1 receptors in 12-well plates, were stimulated with and without Ang II (0.03 and 100 nmol/L) for 10 minutes at 37°C. Surface-bound ligands were removed by a gentle acid wash (50 mmol/L sodium citrate, 0.2 mmol/L sodium phosphate, 90 mmol/L NaCl, and 0.1% BSA, pH 5.0) for 10 minutes at 4°C, which did not affect subsequent receptor binding. Then a radioligand binding assay was performed (5 hours at 4°C) to quantify receptors remaining at the cell surface. Internalized receptors are expressed as a percentage loss of cell surface binding compared with cells not exposed to Ang II.
Immunoblots
Cells that were serum deprived overnight were treated with Ang II in the presence and absence of 100 nmol/L of the EGFR-specific inhibitor AG1478 for 20 minutes. After this, cells were washed twice with ice-cold Dulbecco's PBS. Cells were then lysed on ice with ice-cold lysis buffer (50 mmol/L Tris, pH 7.2, 1% [vol/vol] Triton X-100, 1 mmol/L Na 3 VO 4 , 1 mmol/L EGTA, 0.2 mmol/L phenylmethanesulfonyl fluoride, 25 g/mL leupeptin, and 10 g/mL aprotinin). Samples were then centrifuged at 14 000g for 10 minutes. Protein content in the supernatants was determined by the BCA assay according to manufacturer instructions (Pierce) . A total of 15 g of total cell lysate protein was subjected to SDS-PAGE and then transferred to a polyvinylidene difluoride membrane by electroblotting at 200 mA for 1.5 hours. The membrane was immunoblotted according to a standard Western blot protocol as furnished by the manufacturers, and the immunoreactive proteins were detected by enhanced chemiluminescence (ECL; Amersham Pharmacia Biotech Inc.). An autoradiograph of the blot was analyzed by an OS-Scan Image Analysis System to obtain the densitometry data.
Statistical Analysis
Results are expressed as the meanϮSEM of 3 to 5 independent determinations. The significance in measured values was evaluated using an unpaired Student's t test.
Results
AT 1 Receptor Mutant: Characterization and Ligand Binding
To abolish all G-protein activation activity of the AT 1 receptor, double mutations were introduced into an AT 1 receptor in which the highly conserved Asp 125 and Arg 126 residues were substituted with Ala 125 and Leu 126 as illustrated in Figure 1 . The expression of the wild-type and mutant receptors in COS-1 cells was confirmed by ligand binding and Western blots with 1D4 monoclonal antibody (data not shown). Recombinant expression in transiently transfected COS-1 cells was used for characterization of the AT 1 receptors as described previously. 30, 34 Expression in each case was measured by immunoblotting with a C-terminal epitope-directed monoclonal antibody 1D4, followed by 
Mutant D125A-R126L Fails to Induce GTP-GDP Exchange
The ability of the AT 1 receptor to activate IP production in COS-1 cells has been demonstrated previously in this laboratory. 34 In sharp contrast to the wild-type AT 1 receptors, mutant D125A-R126L failed to produce IP in the presence of Ang II at various concentrations (Figure 2) . Moreover, the basal IP production was negligible, even when the mutant was overexpressed in the COS-1 cells, whereas the wild-type receptor-expressing COS-1 cells produced 2.6% basal IP activity in the absence of any exogenous agonist (Figure 2 ). These IP results were the net IP production after deduction of IP values (Ϸ2.5% or 1000 cpm/10 6 cells) from mocktransfected COS-1 cells.
The complete inability of D125A-R126L in activating the G q /IP pathway may not preclude the possibility that the defective mutant receptor is capable of activating other G-proteins, directly or indirectly, through other mechanisms. To examine this possibility, a series of binding experiments were performed. Figure 3 shows that the mutant receptor was completely insensitive to Mg 2ϩ ( Figure 3B ) and GTP␥S ( Figure 3C ), whereas the wild-type receptor displayed an increased binding affinity for the agonist Ang II ( Figure 3A ) in the presence of Mg 2ϩ and a decreased binding affinity for the agonist 125 I-Ang II in the presence of GTP␥S ( Figure 3C ). This result indicates that the mutant receptor did not directly couple to any G-proteins.
To examine whether the mutant receptors directly or indirectly induced GTP-GDP exchange, GTP␥S and GDP exchange assays were performed. Consistent with the above binding assays, stimulation of the mutant receptor with Ang II failed to induce any GTP-GDP exchange mediated by G-proteins, suggesting no activation of any G ␣ proteins. In contrast, the wild-type receptor elicited an apparent GTP-GDP exchange, indicating activation of G-proteins (Figure 4 ).
Mutant D125A-R126L Still Internalizes
In view of the apparent difference in G-protein coupling and activation between mutant D125A-R126L and the wild-type AT 1 Figure 1 . The secondary structure model of the rat AT 1 receptor. Putative ␣-helical transmembrane domains I-VII, 3 potential glycosylation sites, and 2 disulfide bonds are shown. Residues and motifs in closed black circles are highly conserved in Ͼ90% of GPCRs. The amino acids in the cytoplasmic tail of the receptor that have been suggested to be important for receptor internalization are shaded. The membrane interface boundaries for all 7 TM helices are tentative. ]Ang II failed to induce internalization of either receptor ( Figure 5A ), consistent with a previous report. 33 Because GRK2 is known to play an important role in initiation of homologous internalization of AT 1 receptors, overexpression of a dominant-negative R220K mutant GRK2 was used in the study and reduced the internalization to 24.2% and 18.3% for the wild-type and mutant receptors, respectively ( Figure 5 ). These reductions reflected 53.1% and 60% decreases in the capacity of receptor internalization. Interestingly, the magnitude of the reduction in the mutant receptor was 6.9% greater compared with the wild type (PϽ0.05). These changes in magnitude are also apparent when the kinetics of receptor internalization is plotted as shown in Figure 5B . However, no changes in the time course of internalization were observed between the wild-type and mutant receptors in the presence and absence of R220K expression. Also AG1478, an EFGR kinase-specific inhibitor, failed to affect internalization of either receptor.
In the absence of Ang II, the heterologous internalization of the wild-type and mutant D125A-R126L was negligible under the experimental conditions, as detected by saturation binding assays with 125 
Mutant D125A-R126L Receptor Transactivates EGFRs
Because D125A-R126L still underwent almost normal homologous internalization, it must have initiated certain specific signals that preceded the internalization. To identify the specific D125A-R126L-initiated signals, transactivation of EGFR was examined. In the presence or absence of EGFR 
Discussion
Internalization plays an important role in receptor desensitization, endocytosis, and signal transduction. Heterologous internalization of a GPCR is a passive process that does not require a specific agonist binding to the receptor. However, homologous internalization of a GPCR is an active process that requires the following: (1) specific ligand binding, (2) a conformational change of the receptor, (3) GRK-mediated phosphorylation of the receptor, and (4) signal transductions initiated by the activated receptor. It is generally believed that conventional homologous internalization of a GPCR depends on the activation of G-proteins because activation of GRKs requires preactivation of G-proteins (Figure 7) . To determine whether non-G-protein signals, also activated by a GPCR, might also trigger homologous internalization of the receptor, a mutant receptor that would still interact with the agonist but fail to activate G-proteins was required. The AT 1 mutant receptor D125A-R126L was constructed to serve this purpose ( Figure 1 ). This mutant receptor showed unimpaired agonist binding capacity but failed to activate any G-protein. Therefore, it would be anticipated that the mutant receptor would no longer be able to undergo conventional homologous internalization because it no longer activated G-proteins or GRKs. To our surprise, the mutant receptor showed almost normal homologous internalization in the presence of agonist Ang II at high (100 nmol/L) and low (0.03 nmol/L) levels. The finding at low level of Ang II is consistent with previous observations made by Gaborik et al with a similar double-mutant DRY/AAY. 35, 36 This result indicates that homologous internalization of the AT 1 receptor is also inducible through mechanisms distinct from G-protein activation. The type of homologous internalization induced through G-protein activation-independent mechanisms is therefore "unconventional" (Figure 7) .
Phosphorylation of an activated GPCR by GRKs is a tightly regulated process. Activation of these GRKs often requires activated G-proteins. For example, activation of GRK2 requires double binding of the activated G ␣q and G ␤ ␥ dimer to the N-terminal regulator of G-protein signaling (RGS)-like domain and the C-terminal pH domain of GRK2. [37] [38] [39] The K220R mutant GRK2 is deficient only in its protein kinase activity. Its binding capacity to proteins such as G ␣q and G ␤ ␥ remains intact. It is known that GRK2, GRK3, and GRK5 phosphorylate activated AT 1 receptors, and expression of the dominant-negative K220R mutant GRK2 causes Ϸ50% inhibition of the wild-type AT 1 internalization. 40 However, our results suggest that GRKs still played an important role in inducing internalization of the mutant D125A-R126L. This suggests that the GRKs could be activated through G-proteinindependent mechanisms because the dominant-negative K220R mutant GRK2 also diminished "unconventional" homologous internalization of the mutant D125A-R126L. This calls for further study of the mechanisms of GRK activation. Indeed, a recent report has shown that the N-terminal RGS-like domain of the GRK2 also binds to the metabotropic glutamate receptor 
Feng et al
Unconventional Internalization of the AT 1 Receptor 5 1a. 39 Other examples suggesting G-protein-independent activation of GRKs are the findings that GRK2 desensitizes the PDGF␤ receptor and GRK3 mediates P2X 7 receptor internalization because activation of neither PDGF receptor nor P2X 7 receptor activates G-proteins. 41, 42 It has been documented that homologous internalization of AT 1 receptors can take place through ␤-arrestin-dependent and -independent pathways depending on the concentration of Ang II. The ␤-arrestin-dependent pathway plays a major role at low concentration (0.03 nmol/L), whereas ␤-arrestinindependent pathway becomes predominant at saturation concentration of Ang II (100 nmol/L). 6, 35, 43 Our results show that the mutant D125A-R126L receptor, similar to the wild type, can use both pathways for homologous internalization. Most important, the ␤-arrestin-independent internalization of the mutant receptor occurs independently of G-protein activation. The inability of [Sar 1 ,Ile 4 ,Ile 8 ]Ang II to induce internalization of the AT 1 receptors may further support the presence of ␤-arrestin-independent pathway because this inactive Ang II analog can induce association of the receptors with ␤-arrestin as reported by Wei et al. 44 It is at least theoretically possible that binding of agonist Ang II to mutant D125A-R126L may result in an indirect activation of G-proteins. This assumption is based on the fact that AT 1 receptors may act in the form of a homodimer and heterodimer with AT 1 , AT 2 , bradykinin B 2 , ␤ 2 -adrenergic, and dopamine D 1 receptors. 19 -26 Defective mutant AT 1 receptors may restore its wild-type-like full function through forming homodimers to rescue its activity, as reported previously. 22 However, our results do not support this possibility because there was no GTP-GDP exchange detected under our experimental conditions. Similar to many GPCRs, AT 1 receptors also initiate multiple signals transduced through activation of classical trimeric G-proteins and transactivation of receptor tyrosine kinase EGFR and PDGF receptor. 14 -18 Subsequent internalization of the activated AT 1 receptors leads to activation of ERK1/2. 44, 45 However, the signals that trigger homologous internalization of the AT 1 receptor remain unknown although the G-proteinindependent homologous internalization has been reported. 36, 44 It is also unknown whether altered or activated conformation alone of the AT 1 receptor can trigger homologous internalization by recruiting ␤-arrestins or other molecules such as caveolin and GRKs. Our results suggest that the G-protein-independent homologous internalization of the mutant D125A-R126L could be initiated by G-protein-independent signals that transactivate EGFR. However, in the present study, we were unable to identify the exact signal that might have triggered the receptor internalization because the detailed mechanism leading to EGFR transactivation remains largely unknown. The fact that the EGFR-specific inhibitor AG1478 failed to block the homologous internalization of the mutant AT 1 receptor suggests that the internalizationtriggering signal is upstream of the transactivation of EGFR.
Perspectives
This study showed that ␤-arrestin-dependent and -independent homologous internalizations could take place independently of G-protein activation. The G-protein-independent signals initiated by AT 1 receptors may also trigger homologous internalization. This may represent a general mechanism for triggering GPCR internalization. Our results also suggest that GRKs might be activated through G-protein-independent mechanisms, and the AT 1 -mediated transactivation of EGFR is not only G-protein independent but also internalization independent. Internalization-triggering signals and internalization of the AT 1 receptors. a, Mechanism of heterologous internalization initiated by PKA and PKC; b, mechanism of conventional homologous internalization initiated by an activated G-proteins; c, mechanism of unconventional homologous internalization initiated by G-protein-independent signals; d, ␤-arrestin-dependent internalization (binding of ␤-arrestins to a GPCR is essential); e, ␤-arrestin-independent internalization (binding of other non-␤-arrestin molecules such as caveolin or GRK2 is essential). Here, R*, dR*, and iR* means activated, desensitized, and internalized AT 1 receptors, respectively. In this illustration, GRKs play an important role in G-protein-dependent conventional homologous internalization and G-protein-independent unconventional homologous internalization. Other kinases may also be involved in the initiation of homologous internalizations of the AT 1 receptor. Transactivation of EGFR is not only independent of AT 1 receptor internalization but also independent of G-protein activation.
